Previous 10 | Next 10 |
Clinical Trial Cohort to Evaluate SY-5609 in Combination with Atezolizumab, a PD-L1 Checkpoint Inhibitor Marks First Clinical Investigation of Selective CDK7 Inhibitor with Immunotherapy Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines th...
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, August 5, 2021 to report its second quarter 2021 financial results and pr...
Shares of Syros Pharmaceuticals Inc. (NASDAQ:SYRS) traded today at $4.44, breaking its 52-week low. So far today approximately 771,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. In the past 52 weeks, Syros Pharmaceuticals Inc. share prices ...
SYRS has a pivotal trial in MDS going on, with data next year. Their pipeline is varied, with multiple shots on goal. The cash position is also strong. For further details see: Syros: Pivotal Trial In MDS Ongoing
Analysts Are Boosting Ratings & Targets For These Current & Former Penny Stocks Penny stocks can be some of the most exciting types of stocks in the market. Few other asset classes offer such potential to see significant returns in such a short period of time. Now, by definition...
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities 2021 Life Sciences Conference. Details ar...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips You don’t need a financial expert or anyone of any credentials to tell you why penny stocks are so appealing. That’s akin to explaining how the dazzling lights and sounds of Las Vegas might lure in tourists fr...
Vertex Energy (VTNR) +28%.Cloudera CLDR +24% on being acquired by Clayton, Dubilier & Rice and KKR for $5.3 billion.Orbsat Corp Common Stock (OSAT) +19%.AMC Entertainment Holdings AMC +16% on raising $230.0 million.Lineage Cell Therapeutics LCTX +14% on updat...
Vertex Energy (VTNR) +49%.Iterum Therapeutics plc (ITRM) +21% after sulopenem NDA update.Yext (YEXT) +13% on Q1 earnings.Koss Corporation (KOSS) +13%.AMC Entertainment Holdings (AMC) +12%.MDJM Ltd (MDJH) +12%.Titan Medical (TMDI) +11% on milestone payment of $10M under licensin...
Syros Pharmaceuticals (SYRS) shares are up more than 18% in afternoon trading, a day after Cathie Wood's ARK Innovation ETF (ARKK) liquidated its position in the company.Wood unloaded ~3.6M Syros shares yesterday, which represented 0.09% of the fund's holdings.One possible explanati...
News, Short Squeeze, Breakout and More Instantly...
Syros Pharmaceuticals Inc. Company Name:
SYRS Stock Symbol:
NASDAQ Market:
Syros Pharmaceuticals Inc. Website:
-- Pivotal Complete Response (CR) Data from SELECT-MDS-1 Phase 3 Trial Expected by Mid-4Q24 -- -- Additional Data from SELECT-AML-1 Phase 2 Trial Expected in September 2024-- -- Management to Host Conference Call at 8:30 AM ET Today -- Syros Pharmaceuticals (NA...
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, July 31, 2024 to report its s...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...